Small Molecules
21 March 2016
ContraVir Initiates Phase 1/2a Clinical Study of CMX157 for Treating Chronic Hepatitis B Infection21 March 2016
Cerulean Presents CRLX301 Phase 1 Data at the 14th International Congress on Targeted Anticancer Therapies21 March 2016
Chi-Med Initiates Sulfatinib Phase III Registration Study in Pancreatic Neuroendocrine Tumor Patients21 March 2016
LEO Pharma Receives Scientific Approval of Enstilar® for the Treatment of Psoriasis in EU19 March 2016
Millendo Therapeutics Announces Publication of Preclinical Data for ATR-101 and Data Presentations at ENDO 201619 March 2016
Oral Ozanimod Showed Histologic Improvements in Patients with Ulcerative Colitis in the Phase 2 TOUCHSTONE Trial18 March 2016
Results from 10-week analysis of Phase 2 study with filgotinib in Crohn’s Disease presented at ECCO18 March 2016
FDA Rules Favorably On Efficacy Of Travivo™ (Gepirone ER) For Treatment Of Major Depressive Disorder18 March 2016
Vitae Pharmaceuticals Achieves Proof-of-Concept with First-in-Class RORyt Inhibitor in Moderate to Severe Psoriasis17 March 2016
Axsome Therapeutics Initiates Phase 3 Study of AXS-05 for Treatment Resistant Depression17 March 2016
GSK’s Advair® Diskus® achieves primary endpoint in LABA safety study of children aged 4-11 years with asthma17 March 2016
TopiVert Reports Successful Phase I Study With TOP1288 for the Treatment Of Ulcerative Colitis17 March 2016
Biotron Phase 2 Hepatitis C Trial SuccessNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports